Spring Creek Capital’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Spring Creek Capital’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-135,500	Closed	-$1.37M	–	113
2022 Q1	$1.37M	Buy	+135,500	New	+$1.36M	0.05%	336

Other funds holding OCEA

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return

Spring Creek Capital's OCEA Position: Q2 2022 in Review

Spring Creek Capital sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2022, closing a stake of 135,500 shares — an estimated $1.37M sold.

Spring Creek Capital first reported a position in OCEA in Q1 2022 and held it in 1 quarter. The position peaked at $1.37M in Q1 2022. 35 funds tracked by Wall St. Rank hold OCEA as of Q2 2022.

Spring Creek Capital reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Spring Creek Capital sold 135,500 Ocean Biomedical, Inc. Common Stock shares in Q2 2022, an estimated $1.37M.
Spring Creek Capital first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
Spring Creek Capital's Ocean Biomedical, Inc. Common Stock position peaked at $1.37M in Q1 2022.
35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.